Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy

Kidney International

Volumn 49, Issue 6, 1996, Pages 1778-1782

  Parving, Hans Henrik ^a   Jacobsen, Peter ^a   Rossing, Kasper ^a   Smidt, Ulla M ^a   Hommel, Eva ^a   Rossing, Peter ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029995388     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.266     Document Type: Conference Paper

References (26)

1. ANDERSEN AR, CHRISTIANSEN JS, ANDERSEN JK, KREINER S, DECKERT T: Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
2. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in Type 1 diabetes. Am J Med 78:785-794, 1985
3. BORCH-JOHNSEN K, ANDERSEN PK, DECKERT T: The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
4. ROSSING P, ROSSING K, JACOBSEN P, PARVING H-H: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 44: 734-743, 1995
5. EGGERS PW: Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318:223-229, 1988
6. BORCH-JOHNSEN K, KREINER S: Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 294:1651-1654, 1987
7. KNOWLES HCJ: Long term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians 84:95-101, 1971
8. MOGENSEN CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
9. PARVING H-H, ANDERSEN AR, SMIDT UM, SVENDSEN PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1179, 1983
10. PARVING H-H, ANDERSEN AR, SMIDT UM, HOMMEL E, MATHIESEN ER, SVENDSEN PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
11. PARVING H-H, ROSSING P: The use of antihypertensive agents in prevention and treatment at diabetic nephropathy. Curr Opin Nephrol Hypertens 3:292-300, 1994
12. BJÖRCK S, NYBERG G, MULEC H, GRANERUS G, HERLITZ H, AURELL M: Beneficial effect of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:471-474, 1986
13. BJÖRCK S, MULEC H, JOHNSEN SA, NORDÉN G, AURELL M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-343, 1992
14. PARVING H-H, HOMMEL E, SMIDT UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 297:1086-1091, 1988
15. LEWIS E, HUNSICKER L, BAIN R, RHODE R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
16. PARVING H-H, HOMMEL E: Prognosis in diabetic nephropathy. Br Med J 299:230-233, 1989
17. LARSEN K: Creatinine assay by a reaction - kinetic principle. Clin Chim Acta 41:209-217, 1972
18. PARVING H-H, SMIDT UM, FRIISBERG B, BONNEVIE-NIELSEN V, ANDERSEN AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20:457-461, 1981
19. VIBERTI GC, BILOUS RW, MACKINTOSH D, KEEN H: Monitoring glomerular function in diabetic nephropathy. Am J Med 74:256-264, 1983
20. ZELLER KR, WHITTAKER E, SULLIVAN L, RASKIN P, JACOBSON HR: Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes melitus. N Engl J Med 324:78-84, 1991
21. WALKER JD, BENDING JJ, DODDS RA, MATTOCK MB, MURRELLS TJ, KEEN H, VIBERTI GC: Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet ii:1411-1415, 1989
22. NYBERG G, BLOHMÉ G, NORDÉN G: Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 30:82-86, 1987
23. PARVING H-H, ROSSING P, HOMMEL E, SMIDT UM: Angiotensin converting enzyme inhibition in diabetic nephropathy: Ten years experience. Am J Kidney Dis 26:99-107, 1995
24. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR: Hypercholesterolemia-A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 45(Suppl 45):S125-S131, 1994
25. SAWICKI PT, BENDER R, DIDJURGEIT U, HEINEMANN L, MUHLHAUSER I, BERGER M: Smoking is associated with progression of diabetic nephropathy. Diabetics Care 17:126-131, 1994
26. MATHIESEN ER, BORCH-JOHNSEN K, JENSEN DV, DECKERT T: Improved survival in patients with diabetic nephropathy. Diabetologia 32:884-886, 1989